Ticker
NAOVCompany Name
NANOVIBRONIX INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -4.33M | -184.91% | $ 2.34M |
3/31/2025 | $ -5.41M | -203.31% | $ 2.66M |
12/31/2024 | $ -3.58M | -139.99% | $ 2.56M |
9/30/2024 | $ -2.91M | -88.51% | $ 3.29M |
6/30/2024 | $ -2.61M | -77.47% | $ 3.37M |
3/31/2024 | $ -2.95M | -103.47% | $ 2.85M |
12/31/2023 | $ -3.44M | -150.46% | $ 2.28M |
9/30/2023 | $ -4.44M | -442.33% | $ 1M |
6/30/2023 | $ -4.69M | -730.02% | $ 643K |
3/31/2023 | $ -4.97M | -596.04% | $ 834K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for NANOVIBRONIX INC is calculated as follows: EBITDA [ $ -4.42M ] / Revenues [ $ 620K ]
(=) EBITDA % [ -712.1% ]
Minimum
Mar 31, 2021
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.29K |
---|---|
min | -74.33% |
max | 97.24% |
average | 16.2% |
median | 14.74% |
std | 26.73% |